← All trials
NCT02099240
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2014
- Primary completion
- Sep 1, 2019
- Completion date
- Sep 1, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 456
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of LouisvilleLead sponsor
- James Graham Brown Cancer CenterCollaborator
- University of LouisvilleCollaborator
- University of LouisvilleOverall official - principal investigator
- University of LouisvilleSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.